TrialBlood cancer journal2014

Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients.

R E Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.